Skip to content

Type: White Papers

2017 Annual Meeting: Capitalizing on the Totality of Evidence to Streamline Approvals for Supplemental Indications

Streamlining Approval of Supplemental Indications

Trends in the Molecular Diagnosis of Lung Cancer: Results from an Online Market Research Survey

Accelerating Pediatric Drug Development: Session 1 – Challenges & Opportunities in Pediatric Oncology Drug Development

2016 Annual Meeting: Optimization of Exploratory Randomized Trials

2016 Annual Meeting: Examining the Feasibility of Real World Evidence Through Pilot Studies

2016 Annual Meeting: Modernization of Eligibility Criteria

Friends 2016 Annual Meeting Report and Issue Briefs

Blueprint for Breakthrough: Exploring the Utility of Real World Evidence (RWE) – Pre-Meeting Draft White Paper

Conference on Clinical Cancer Research 2008: Panel Three – Co-Development of Diagnostics and Therapeutics